SCHEMBL9867758

SCHEMBL9867758

COc1cccc(-c2nsc(SN)n2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.52
CLK4 Q9HAZ1 2/20 0.50
DYRK1A Q13627 1/20 0.50
NR1H2 P55055 2/20 0.48
NR1H3 Q13133 2/20 0.48
DCUN1D1 Q96GG9 1/20 0.45
ADORA2A P29274 2/20 0.44
ADORA1 P30542 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
CYP1A2 P05177 5/20 0.44
CYP3A4 P08684 5/20 0.44
CYP2C9 P11712 4/20 0.44
CYP2D6 P10635 4/20 0.44
CYP2B6 P20813 2/20 0.44
AHR P35869 2/20 0.44
NR1I3 Q14994 2/20 0.44
VDR P11473 1/20 0.44
SMN1; SMN2 Q16637 6/20 0.43
RAB9A P51151 4/20 0.43
TP53 P04637 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24217518 0.83 CYP19A1 (0.50) CYP19A1CLK4DYRK1ANR1H2NR1H3
SCHEMBL9867822 0.82 MAPT (0.55) CLK4ADORA3SMN1; SMN2RAB9ATP53
SCHEMBL9867907 0.81 ALDH1A1 (0.54) CYP1A2CYP3A4CYP2C9CYP2D6NR1I3
SCHEMBL25333739 0.80 CYP19A1 (0.47) CYP19A1CLK4DYRK1ANR1H2NR1H3
SCHEMBL30423929 0.79 CYP19A1 (0.57) CYP19A1CLK4DYRK1ANR1H2NR1H3
SCHEMBL24217120 0.79 CYP19A1 (0.57) CYP19A1CLK4DYRK1ANR1H2NR1H3
SCHEMBL20320401 0.79 DYRK1A (0.60) CYP19A1CLK4DYRK1ANR1H2NR1H3
SCHEMBL9867185 0.78 ALDH1A1 (0.45) CYP19A1ADORA2AADORA1ADORA3ATP4A
SCHEMBL14488273 0.78 CYP19A1 (0.56) CYP19A1CLK4DYRK1ANR1H2NR1H3
SCHEMBL9867784 0.78 CYP19A1 (0.56) CYP19A1CLK4DYRK1ANR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US claimed
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US disclosed
US-4873239-A GLAUCOMA TREATMENT HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-10-10 US disclosed
EP-0276822-A1 Arylthiadiazolylsulfonamides and derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-08-03 EP disclosed
US-4758578-A Arylthiadiazolylsulfonamides, pharmaceutical compositions and use HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) 1988-07-19 US disclosed